10/30/2015 - 2:15pm

A new maintenance treatment for COPD from Novartis has been approved by the FDA. 

10/30/2015 - 1:37pm

Patients prescribed Auvi-Q should contact their doctor for a prescription for a new epinephrine auto-injector, Sanofi’s chief medical officer said, and they should also call 877-319-8963 or 866-726-6340 for information about returning the auto-injector and a reimbursement, if needed

10/30/2015 - 10:43am

Perrigo’s motion for an injunction against Mylan’s proposed acquisition was not granted in New York’s Southern District Court. 

10/29/2015 - 5:03pm

Forbes is reporting that CVS and Express Scripts have cut ties with Valeant Pharmaceuticals’ specialty pharmacy Philidor Rx amid investigations into the company’s business practices. “In accordance with CVS/caremark’s standard auditing protocols, over the last several weeks we have been monitoring and reviewing the results of recent audits of Philidor’s practices,” CVS said in a statement. ”Based on the findings from those activities, we have terminated Philidor for noncompliance with the terms of its provider agreement.” (Forbes)

10/29/2015 - 12:12pm

The company would not comment on th

10/29/2015 - 10:35am

McKesson's North America pharmaceutical distribution and services revenues were $40.6 billion for the quarter, up 16% on a reported basis and 17% on a constant currency basis. 

10/28/2015 - 2:15pm

HealthDay is reporting that researchers fromt the University of Michigan’s Survey Research Center have found that a person’s use of narcotic painkillers as a teen raises their risk of abuse as an adult by 33%. “Most likely, the initial experience of pain relief is pleasurable and a safe initial experience may reduce perceived danger,” the study’s author Richard Miech said. “A pleasurable and safe initial experience with a drug is a central factor in theories of who goes on to misuse drugs.” (HealthDay)

10/28/2015 - 1:32pm

Amgen announced Wednesday that it had received approval from the Food and Drug Administration for Imlygic (talimogene laherparepvec) for injection.

10/28/2015 - 12:30pm

The drug, which gained FDA approval in July, is indicated to treat papules and pustules associated with rosacea.